Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Durlach

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|March 15, 2022
[Lipoprotein (a) :NSFA consensus]Vincent Durlach, Eduardo Anglés-Cano
Cardiology and Therapy|May 11, 2025
Patient Experience of Heart Disease with Elevated Lipoprotein(a): Views from a Patient, His Physician, and a Patient AssociationStéphane Favereaux, Vincent Durlach, Bernard Vercoustre
Thrombosis and Haemostasis|August 23, 2005
Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasmaMarina Nardulli, Vincent Durlach, Gabriella Pepe, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2003
Study of apo(a) length polymorphism and lipoprotein(a) concentrations in subjects with single or double apo(a) isoformsMariam Alaoui, Corinne Merle, Roselyne Garnotel, et al.
Primary Care Diabetes|January 31, 2024
Tobacco smoking and diabetes. A comparative survey among diabetologists and smoking cessation specialistsIvan Berlin, Vincent Durlach, Daniel Thomas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibodyChantal Kang, Miguel Dominguez, Stéphane Loyau, et al.
The Canadian Journal of Cardiology|January 26, 2023
Smoking and Diabetes: Sex and Gender Aspects and Their Effect on Vascular DiseasesBlandine Tramunt, Alexia Rouland, Vincent Durlach, et al.
Diabetes|April 21, 2012
Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530Antonio Brunetti, Eusebio Chiefari, Clive R Pullinger, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 22, 2016
Circadian disturbance and idiopathic central serous chorioretinopathyElodie Setrouk, Beatrice Hubault, Frédérique Vankemmel, et al.
Atherosclerosis Plus|January 16, 2023
Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemiaJean Ferrières, Michel Farnier, Eric Bruckert, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|March 15, 2022
[Lipoprotein (a) :NSFA consensus]Vincent Durlach, Eduardo Anglés-Cano
Cardiology and Therapy|May 11, 2025
Patient Experience of Heart Disease with Elevated Lipoprotein(a): Views from a Patient, His Physician, and a Patient AssociationStéphane Favereaux, Vincent Durlach, Bernard Vercoustre
Thrombosis and Haemostasis|August 23, 2005
Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasmaMarina Nardulli, Vincent Durlach, Gabriella Pepe, et al.
Clinical Chemistry and Laboratory Medicine|June 19, 2003
Study of apo(a) length polymorphism and lipoprotein(a) concentrations in subjects with single or double apo(a) isoformsMariam Alaoui, Corinne Merle, Roselyne Garnotel, et al.
Primary Care Diabetes|January 31, 2024
Tobacco smoking and diabetes. A comparative survey among diabetologists and smoking cessation specialistsIvan Berlin, Vincent Durlach, Daniel Thomas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibodyChantal Kang, Miguel Dominguez, Stéphane Loyau, et al.
The Canadian Journal of Cardiology|January 26, 2023
Smoking and Diabetes: Sex and Gender Aspects and Their Effect on Vascular DiseasesBlandine Tramunt, Alexia Rouland, Vincent Durlach, et al.
Diabetes|April 21, 2012
Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530Antonio Brunetti, Eusebio Chiefari, Clive R Pullinger, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 22, 2016
Circadian disturbance and idiopathic central serous chorioretinopathyElodie Setrouk, Beatrice Hubault, Frédérique Vankemmel, et al.
Atherosclerosis Plus|January 16, 2023
Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemiaJean Ferrières, Michel Farnier, Eric Bruckert, et al.
Pageof 3